1. Home
  2. LIDR vs ELTX Comparison

LIDR vs ELTX Comparison

Compare LIDR & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIDR
  • ELTX
  • Stock Information
  • Founded
  • LIDR 2013
  • ELTX 2011
  • Country
  • LIDR United States
  • ELTX United States
  • Employees
  • LIDR N/A
  • ELTX N/A
  • Industry
  • LIDR Auto Parts:O.E.M.
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LIDR Consumer Discretionary
  • ELTX Health Care
  • Exchange
  • LIDR Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • LIDR 108.6M
  • ELTX 121.7M
  • IPO Year
  • LIDR N/A
  • ELTX N/A
  • Fundamental
  • Price
  • LIDR $2.71
  • ELTX $11.47
  • Analyst Decision
  • LIDR Strong Buy
  • ELTX Strong Buy
  • Analyst Count
  • LIDR 1
  • ELTX 2
  • Target Price
  • LIDR $6.00
  • ELTX $11.00
  • AVG Volume (30 Days)
  • LIDR 4.2M
  • ELTX 99.4K
  • Earning Date
  • LIDR 11-11-2025
  • ELTX 11-12-2025
  • Dividend Yield
  • LIDR N/A
  • ELTX N/A
  • EPS Growth
  • LIDR N/A
  • ELTX N/A
  • EPS
  • LIDR N/A
  • ELTX N/A
  • Revenue
  • LIDR $236,000.00
  • ELTX N/A
  • Revenue This Year
  • LIDR N/A
  • ELTX N/A
  • Revenue Next Year
  • LIDR $2,991.40
  • ELTX N/A
  • P/E Ratio
  • LIDR N/A
  • ELTX N/A
  • Revenue Growth
  • LIDR N/A
  • ELTX N/A
  • 52 Week Low
  • LIDR $0.49
  • ELTX $4.05
  • 52 Week High
  • LIDR $6.44
  • ELTX $12.62
  • Technical
  • Relative Strength Index (RSI)
  • LIDR 50.64
  • ELTX 56.41
  • Support Level
  • LIDR $2.56
  • ELTX $10.00
  • Resistance Level
  • LIDR $2.75
  • ELTX $12.62
  • Average True Range (ATR)
  • LIDR 0.18
  • ELTX 0.74
  • MACD
  • LIDR -0.05
  • ELTX -0.04
  • Stochastic Oscillator
  • LIDR 25.00
  • ELTX 55.92

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: